Mostrar el registro sencillo del ítem
dc.contributor.author | González Martínez, Silvia | |
dc.contributor.author | Pizarro, David | |
dc.contributor.author | Pérez Mies, Belén | |
dc.contributor.author | Caniego Casas, Tamara | |
dc.contributor.author | Curigliano, Giuseppe | |
dc.contributor.author | Cortés Castán, Javier | |
dc.contributor.author | Palacios, José | |
dc.date.accessioned | 2022-06-23T13:27:10Z | |
dc.date.available | 2022-06-23T13:27:10Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | González-Martínez, S., Pizarro, D., Pérez-Mies, B., Caniego-Casas, T., Curigliano, G., Cortés, J., & Palacios, J. (2021). Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis. Cancers, 13(21), 5416. https://doi.org/10.3390/cancers13215416 | spa |
dc.identifier.issn | 2072-6694 | |
dc.identifier.uri | http://hdl.handle.net/11268/11375 | |
dc.description.abstract | Cutaneous metastases (CMs) account for 2% of all skin malignancies, and nearly 70% of CMs in women originate from breast cancer (BC). CMs are usually associated with poor prognosis, are difficult to treat, and can pose diagnostic problems, such as in histopathological diagnosis when occurring long after development of the primary tumor. In addition, the molecular differences between the primary tumors and their CMs, and between CMs and metastases in other organs, are not well defined. Here, we review the main clinical, pathological, and molecular characteristics of breast cancer CMs. Identifying molecular markers in primary BC that predict CM and can be used to determine the molecular differences between primary tumors and their metastases is of great interest for the design of new therapeutic approaches. | spa |
dc.description.sponsorship | Instituto de Salud Carlos III (ISCIII) (PI19/01331) | spa |
dc.description.sponsorship | CIBERONC (CB16/12/00316, CB16/12/00449) | spa |
dc.description.sponsorship | European Development Regional Fund, ‘A way to achieve Europe’ (FEDER) | spa |
dc.description.sponsorship | Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018) | spa |
dc.language.iso | eng | spa |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.other | Neoplasias de la mama | spa |
dc.subject.other | Neoplasias cutáneas | spa |
dc.subject.other | Metástasis de la neoplasia | spa |
dc.title | Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis | spa |
dc.type | article | spa |
dc.description.impact | 6.575 JCR (2021) Q1, 60/245 Oncology | spa |
dc.description.impact | 1.349 SJR (2021) Q1, 72/369 Oncology | spa |
dc.description.impact | No data IDR 2021 | spa |
dc.identifier.doi | 10.3390/cancers13215416 | |
dc.rights.accessRights | openAccess | spa |
dc.subject.unesco | Cáncer | spa |
dc.subject.unesco | Medicina preventiva | spa |
dc.subject.unesco | Tecnología médica | spa |
dc.description.filiation | UEM | spa |
dc.peerreviewed | Si | spa |